Norwegen - Norwegisch - Statens legemiddelverk

teva b.v. - ambrisentan - tablett, filmdrasjert - 5 mg

Norwegen - Norwegisch - Statens legemiddelverk

teva b.v. - ambrisentan - tablett, filmdrasjert - 10 mg

Norwegen - Norwegisch - Statens legemiddelverk

hexal a/s - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Norwegen - Norwegisch - Statens legemiddelverk

orion corporation - espoo - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Norwegen - Norwegisch - Statens legemiddelverk

oresund pharma aps - natriumnitroprussiddihydrat - pulver til infusjonsvæske, oppløsning - 60 mg

Europäische Union - Norwegisch - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Europäische Union - Norwegisch - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Europäische Union - Norwegisch - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale midler til systemisk bruk - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.

Europäische Union - Norwegisch - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv-infeksjoner - antivirale midler til systemisk bruk - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.

Norwegen - Norwegisch - Statens legemiddelverk

medical valley invest ab - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg